Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The role of pressure feedback in muscle patterning shoulder instability
Source of recordUK Trials
ISRCTNISRCTN65243663
Date ISRCTN assigned29/09/2006
Local reference number(s)N0209167764
Public titleThe role of pressure feedback in muscle patterning shoulder instability
Scientific title
AcronymN/A
Disease/condition/study domainMusculoskeletal Diseases: Shoulder disorders
Study hypothesisDoes the application of tubigrip on the symptomatic arm affect grip strength, dexterity and shoulder movement in patients with muscle patterning instability?
Design/methodologyRandomised controlled trial
Research ethics reviewNo ethics information provided as of 29 September 2006
Countries of trialUnited Kingdom
Participants - inclusion criteria70 patients with symptoms of shoulder instability and/or pain and have a suspicion or diagnosis of muscle patterning abnormality.
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date18/08/2005
Anticipated end date10/01/2006
Status of trialCompleted
Target number of participants70
InterventionsParticipants will have their grip strength assessed, and dexterity measured via the 9-hole peg test. They will then be randomised to receive treatment (tubigrip) or nothing, and asked to rest for 30 minutes. Following a 30-min rest, they will be asked to repeat these tests in front of a second assessor, who is blinded to whether they have received the treatment or not. Both groups will be asked to keep a symptom diary for 14 days.
Primary outcome measure(s)Active range of shoulder movement, grip strength, dexterity, subjective improvement rating by patient.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingRoyal National Orthopaedic Hospital NHS Trust
NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2006 Update - Department of Health
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMiss Anju Jaggi
Contact detailsRNOHT
Royal National Orthopaedic Hospital
Brockley Hill

Stanmore
United Kingdom
HA7 4LP
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN65243663
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central